Samsung nets FDA clearance

Article

Samsung nets FDA clearanceKorean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98

Samsung nets FDA clearance

Korean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98 architecture, although its image server is also available on the Unix platform (

PNN

9/98).

Raypax comprises display software, an image server, a Web server, a film and plain paper printer server, modality interfaces, and a Web-based teleradiology system. Digitizers as well as DICOM and HL7 gateways are available. Samsung also markets a radiology information system.

Samsung, which has U.S. operations in San Jose, CA, plans to install a U.S. beta site for Raypax this month. Raypax is sold through distributors, and Asian sales of Raypax began in April. Beta testing of Raypax was performed at Samsung Medical Center in Seoul.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.